Healthcare resource consumption and related costs of patients estimated with treatment‐resistant depression in Italy
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
PURPOSE: To analyse the healthcare resource consumption and related costs for the Italian National Health System of patients estimated to be affected by treatment-resistant depression (TRD) in Italy. PATIENTS AND METHODS: This was an observational retrospective study based on administrative databases, including those related to residential/semiresidential structures, of Veneto Region and the Local Health Unit of Bergamo in Italy (for a total of around 6 million health-assisted subjects). Between July 2011 and December 2017, all adult patients with a third antidepressant (AD) after ≥2 AD (each one with at least ≥4 weeks duration, ≥1 prescription at maximum dosage reported in datasheets, a grace period ≤30 days when switching AD and treatment maintained ≥9 months) were included. Overall and psychiatry-related healthcare resources consumption and related costs were estimated on a 12-months based analysis. Data were re-proportioned to the Italian population. RESULTS: We have previously estimated a total of 101,455 patients with TRD in Italy (130,049 considering the mean maximum dosage of AD). Of them, 44.2% had at least a psychiatric hospitalization/visit or accessed a residential/semiresidential structure, and 31% added another AD or a mood stabilizer/antipsychotic drug. Patients with at least one psychiatry-related hospitalization increased over the number of antidepressant lines from 12.0% during first line up to 24.5% during fourth line. Direct healthcare costs increased from €4,405 for first line to €9,251 from fifth line onwards. Psychiatry-related costs went from €1,817 (first line) to €4,606 (fifth line onwards) and were mainly driven by residential/semiresidential structures and hospitalizations. CONCLUSION: An upward trend with number of AD lines was observed for all healthcare resource utilization and consequently for all direct costs, thus indicating an increasing burden for patients as they move forward AD lines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Higher indirect costs are also reported in TRD as a consequence of rel atively greater impairment in psychoso cial function, greater need for disability benefits, higher workplace disability and absentee ism, as well as the negative impact on carers 10, 21,24- 35 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [27]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Johnston, K. M., Powell, L. C., Anderson, I. M., Szabo, S., & Cline, S. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.045 · Cited by 321
Jaffe, D. H., Rive, B., & Denee, T. R. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2222-4 · Cited by 237
Amos, T. B., Tandon, N., Lefebvre, P., Pilon, D., Kamstra, R. L., Pivneva, I., & Greenberg, P. E. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11725 · Cited by 144
Ivanova, J. I., Birnbaum, H. G., Kidolezi, Y., Subramanian, G., Khan, S. A., & Stensland, M. D. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.517716 · Cited by 131
A Review of the Conceptualisation and Risk Factors Associated with Treatment-Resistant Depression
Murphy, J. A., Sarris, J., & Byrne, G. J. (2017) · Depression Research and Treatment · doi:10.1155/2017/4176825 · Cited by 67
McIntyre, R. S., Millson, B., & Power, G. S. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.07.045 · Cited by 60
Definition of Treatment-Resistant Depression in the Medicare Population
Bradley N. Gaynes, M. D., Gary Asher, M. D., Gerald Gartlehner, M. D., Valerie Hoffman, P. D., Josh Green, B. A., Erin Boland, M. S. P. H., Linda Lux, M. P. A., Charlotte Randolph, B. A., Carla Bann, P. D., Emmanuel Cokker-Schwimmer, M. P. H., et al. (2018) · Systematic Review Data Repository · doi:10.26300/4j7h-jk02 · Cited by 58
Cepeda, M. S., Reps, J., Fife, D., Blacketer, C., Stang, P., & Ryan, P. (2018) · Depression and Anxiety · doi:10.1002/da.22705 · Cited by 50
Li, G., Zhang, L., DiBernardo, A., Wang, G., Sheehan, J. J., Lee, K., Reutfors, J., & Zhang, Q. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238843 · Cited by 29
Zhdanava, M., Kuvadia, H., Joshi, K., Daly, E., Pilon, D., Rossi, C., Morrison, L., Lefèbvre, P., & Nelson, C. J. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1844645 · Cited by 15
Marcatili, M., Sala, C., Dakanalis, A., Colmegna, F., D’Agostino, A., Gambini, O., Dell’Osso, B. M., Benatti, B., Conti, L., & Clerici, M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320968331 · Cited by 14
Valentina, P. D., Sangiorgi, D., Andretta, M., Ducci, G., Forti, B., Cesare, F. M. P., Gambera, M., Maina, G., Mencacci, C., Mennini, F. S., et al. (2020) · Journal of Psychiatry and Psychiatric Disorders · doi:10.26502/jppd.2572-519x0098 · Cited by 6
Self-citationDepressione resistente al trattamento: stato dell’arte Parte II. Trattamento
Luchini, F., Cosentino, L., Pensabene, L., Mauri, M., & Lattanzi, L. (2014) · Rivista di psichiatria · doi:10.1708/1766.19120 · Cited by 4
Cited by
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Pettorruso, M., Guidotti, R., d’Andrea, G., Risio, L. D., D’Andrea, A., Chiappini, S., Carullo, R., Barlati, S., Zanardi, R., Rosso, G., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115378 · Cited by 65
Maina, G., Adami, M., Ascione, G., Bondi, E., Berardis, D. D., Delmonte, D., Maffezzoli, S., Martinotti, G., Nivoli, A., Ottavianelli, E., et al. (2023) · Annals of General Psychiatry · doi:10.1186/s12991-023-00478-7 · Cited by 67
Self-citationPappa, S., Shah, M., Young, S., Anwar, T., & Ming, T. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.11.022 · Cited by 21
Vitiligo: Epidemiology and Economic Impact
Naldi, L., Pagani, A., & Alduini, C. (2023) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1304s2a315s · Cited by 20
Metadata
- Authors
- Perrone, V., Sangiorgi, D., Andretta, M., Ducci, G., Forti, B., Francesa Morel, P. C., Gambera, M., Maina, G., Mencacci, C., Mennini, F. S., Zanalda, E., & Degli Esposti, L.
- Affiliations
- Azienda ULSS 8 Berica (IT)
- ASL Roma (IT)
- Azienda ULSS n. 1 Dolomiti (IT)
- Ospedale P. Pederzoli – Casa di Cura Privata S.p.a. (IT)
- University of Turin (IT)
- ASST Fatebenefratelli Sacco (IT)
- University of Rome Tor Vergata (IT)
- Ospedale San Luigi Gonzaga (IT)
- Corresponding author
- Perrone, Valentina
- ORCID
- Venue
- ClinicoEconomics and Outcomes Research
- Publisher
- Informa UK Limited
- Published
- 2021-07
- Volume
- Volume 13
- Pages
- 629-635
- ISSN
- 1178-6981 (ISSN-L)
- PMC
- PMC8275098
- OpenAlex
- W3178067180
- Cited by
- 10
- References
- 13
- Citations by year
- 2024: 4 · 2023: 6
- FWCI
- 1.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- ClinicoEconomics and Outcomes Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Repository (Kingston University London) (acceptedVersion, cc-by-nc-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc-sa)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- treatment-resistant depression, healthcare resource utilization, health care costs, psychiatric hospitalization, mood stabilizers, antipsychotic drugs, Italian National Health Service, Veneto, Bergamo
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.